NAMS
#1691
NewAmsterdam Pharma Company N.V. - Ordinary Shares
25.5 9 USD
+0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+2.69%
Changement Mensuel
-8.11%
Evolution sur 6 mois
-15.82%
Changement Annuel
-29.45%
Clôture Précédente
24.9 2
Open
25.5 9
Low
25.5 9
High
25.5 9
Volume
52
Financials
- Market Capitalization 3.06 B
- Employee 100
- Founded 2019
- CEO N/A
- Website www.newamsterdampharma.com
- Headquarter Netherlands
- FIGI N/A
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-15.76
ratio cours/chiffre d'affaires
582.6
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1681 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 39.48 USD | +0.61% | -2.37% | +4.75% | +44.93% | 3.10 B USD | ||
| 1686 |  IRON Disc Medicine, Inc. - Common Stock | 80.05 USD | +1.75% | -2.67% | +4.53% | +29.97% | 3.07 B USD | ||
| 1699 |  BEAM Beam Therapeutics Inc. - Common Stock | 29.29 USD | +0.93% | -2.82% | +9.50% | +57.30% | 3.03 B USD | ||
| 1708 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 23.85 USD | +0.42% | -4.45% | -8.52% | +49.62% | 3.00 B USD |